Japan's Aska Pharmaceutical Says U.S. Investment Fund Dalton Investments Notified Company About Possibility For Increasing Stake To Up To About 30%
ReutersAug 18, 2025 7:20 AM
Aug 18 (Reuters) - ASKA Pharmaceutical Holdings Co Ltd 4886.T:
JAPAN'S ASKA PHARMACEUTICAL SAYS U.S. INVESTMENT FUND DALTON INVESTMENTS NOTIFIED COMPANY ABOUT POSSIBILITY FOR INCREASING STAKE TO UP TO ABOUT 30%
JAPAN'S ASKA PHARMACEUTICAL: DALTON SAID IT MIGHT NOT BUY UP THE COMPANY STAKES OR SELL THEM DEPENDING ON SITUATION
ASKA PHARMACEUTICAL: DALTON SAID IT SHOULD BE OUR MANAGEMENT TO DECIDE WHETHER TO GO PRIVATE
Source text: [ID:]
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey
Related Articles
Circle’s Next Chapter: Not Just Stablecoins, But a Payments Network
TradingKey - Stablecoins are meeting real-world demand, especially in emerging markets where payment systems are oftenfragmented, access to the traditional banking system is limited, or capital controls restrict seamless global flows.TradingKey
Sat, Sep 20
What Is Worldcoin? Why Did WLD Surge Suddenly, and What’s Next?
Worldcoin is evolving from a “hype token” into a foundational layer for global identity. Its fusion of biometrics, blockchain, and financial inclusion has earned growing recognition from users and institutions. If it can overcome technical hurdles, launch real-world payment use cases, and stabilizeTradingKey
Fri, Sep 12
Unlocking Gold’s Next Leg: $4,000 in Reach by 2025？
TradingKey - Gold has kicked off a fresh uptrend in early September, breaking out of months of compression and reclaiming key territory. The decisive move above $3,500 establishes a new support base and puts higher objectives back on the table for the weeks aheadTradingKey
Thu, Sep 4
Bitcoin Price Forecast: Trends and Investment Outlook from 2025 to 2030
From $0.01 in 2009 to $120,000+ in 2025, Bitcoin has evolved from obscurity to a globally recognized financial asset. While institutions and governments increasingly embrace it, investors must remain vigilant against volatility, security risks, and scams.TradingKey
Wed, Jul 16
ASML Q2 FY2025 Earnings Review: Strong Growth and High-NA EUV Breakthrough Shadowed by 2026 Uncertainty
ASML Holding N.V. (NASDAQ: ASML) released its Q2 FY2025 earnings on July 16, 2025, exceeding market expectations with robust net sales and net bookings, though the stock fell around 10% due to cautious guidance for 2026 amid geopolitical uncertainties.TradingKey
Mon, Jul 14
Tradingkey
